We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Based Automated Quantitative Coronary Angiography Accurately Analyzes Heart Disease

By HospiMedica International staff writers
Posted on 15 Jun 2023
Print article
Image: The AI-based technology offers accurate analysis of cardiac disease (Photo courtesy of Freepik)
Image: The AI-based technology offers accurate analysis of cardiac disease (Photo courtesy of Freepik)

Coronary angiography, a common diagnostic procedure for the treatment of coronary artery disease, requires precise quantitative analysis of stenotic lesions in the coronary artery for optimal clinical decision-making. Stenotic lesions can cause the coronary arteries to narrow, limiting blood flow to the heart. Intravascular ultrasound (IVUS) is a common imaging tool used for evaluating these lesions. With the advent of advanced computer vision and machine learning technology, the automated analysis of coronary angiography has become possible. Now, new research has revealed that artificial intelligence (AI) technology holds significant potential in analyzing coronary angiography.

A study carried out by researchers at Uijeongbu Eulji University Hospital (Uijeongbu, Korea) has demonstrated how AI-based quantitative coronary angiography (AI-QCA) can enhance clinical decision-making. AI-QCA can automatically analyze 2D angiography images and assist physicians in determining the best stent sizes. This technology could enhance patient outcomes and aid clinical decision-making by providing an innovative method to analyze coronary angiography images, offering automated and real-time insights.

The AI-QCA analysis was performed using Medipixel’s (Seoul, Korea) newly-developed MPXA-2000 software which uses an algorithm designed to mimic the QCA process by human experts. The analysis involved 54 significant lesions from 47 patients who underwent IVUS-guided coronary intervention. The researchers discovered that AI-QCA yielded accurate and consistent measurements of coronary stenotic lesions, comparable to IVUS, indicating its potential for safe use in clinical practice. This study represents a significant advancement in the application of AI in enhancing cardiovascular care. Although the study's results are promising, additional research is needed to fully understand the clinical utility and safety of AI-QCA.

“We believe that this novel tool could provide confidence to treating physicians and help in making optimal clinical decisions,” said Dr. In Tae Moon, the lead author of the study.

Related Links:
Uijeongbu Eulji University Hospital 
Medipixel

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Print article

Channels

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.